Top Markets
Coin of the day
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Classement en actions #17313
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Prix de l'action
$1.21
Capitalisation boursière
$248.41M
Changement (1 jour)
4.11%
Changement (1 an)
79.12%
Pays
TW
Échange TWi Biotechnology, Inc. (6610)

Catégorie

Le prix 6610 avec la capitalisation boursière de B
TWi Biotechnology, Inc. TWi Biotechnology, Inc.
6610
$1.21
Capitalisation boursière de TWi Biotechnology, Inc.(6610)
Capitalisation boursière: $248.41M
En September 2026, TWi Biotechnology, Inc. a une capitalisation boursière de $248.41M. Cela fait de TWi Biotechnology, Inc. la 17313th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de TWi Biotechnology, Inc. du 2016 au 2026
6610 par rapport au top 5 des plus populaires stocks
Prix pour 6610 L’actif B La capitalisation boursière de B Résultats
TWi Biotechnology, Inc. TWi Biotechnology, Inc.
$26,707.09 $248.41M
$5.490T +2,210,087.32%
TWi Biotechnology, Inc. TWi Biotechnology, Inc.
$23,187.14 $248.41M
$4.767T +1,918,788.38%
TWi Biotechnology, Inc. TWi Biotechnology, Inc.
$19,628.40 $248.41M
$4.035T +1,624,279.64%
TWi Biotechnology, Inc. TWi Biotechnology, Inc.
$18,008.62 $248.41M
$3.702T +1,490,231.68%
TWi Biotechnology, Inc. TWi Biotechnology, Inc.
$13,359.99 $248.41M
$2.747T +1,105,527.38%